Trial Profile
Pharmacokinetics and Pharmacodynamics of Platelet P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention (PCI) for Acute Myocardial Infarction: A Pilot Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Clopidogrel
- Indications Myocardial infarction
- Focus Pharmacodynamics; Pharmacokinetics
- Acronyms P3AMI
- 03 Jun 2019 Status changed from recruiting to completed.
- 14 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 14 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.